drugset / Trial / NCT00040313
Pegaptanib Sodium Compared to Sham Injection in Patients With DME Involving the Center of the Macula
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to determine whether pegaptanib sodium (Macugen) is safe and effective in slowing the leakage of fluid within the retina and thereby stabilizing or improving vision when compared to placebo injections. A total of 176 patients will be enrolled
Timeline
- Start
- 2002-10
- Primary completion
- —
- Completion
- 2005-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | pegaptanib sodium | Aptamer | — | Intravitreal |